These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30632884)

  • 1. Relationship Between Different Resistance Mechanisms and Virulence in
    Espinal P; Pantel A; Rolo D; Marti S; López-Rojas R; Smani Y; Pachón J; Vila J; Lavigne JP
    Microb Drug Resist; 2019 Jun; 25(5):752-760. PubMed ID: 30632884
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
    Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
    Al-Agamy MH; Jeannot K; El-Mahdy TS; Shibl AM; Kattan W; Plésiat P; Courvalin P
    Microb Drug Resist; 2017 Jul; 23(5):556-562. PubMed ID: 27854148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
    Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
    mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SPECTRUM OF ANTIBIOTIC RESISTANCE AND PREVALENCE OF OXA-CARBAPENEMASES AMONG ACINETOBACTER BAUMANNII STRAINS, ISOLATED FROM PATIENTS OF SURGICAL AND REANIMATION DEPARTMENTS IN MOSCOW].
    Kryzhanovskaya OA; Lazareva AV; Chebotar IV; Bocharova YA; Mayansky NA
    Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):40-5. PubMed ID: 27029115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic characterization of extensively drug-resistant Acinetobacter baumannii strain, KAB03 belonging to ST451 from Korea.
    Lee SY; Oh MH; Yun SH; Choi CW; Park EC; Song HS; Lee H; Yi YS; Shin J; Chung C; Moon JY; Lee JC; Kim GH; Kim SI
    Infect Genet Evol; 2018 Nov; 65():150-158. PubMed ID: 30053642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
    Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
    Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.
    Biglari S; Hanafiah A; Mohd Puzi S; Ramli R; Rahman M; Lopes BS
    Microb Drug Resist; 2017 Jul; 23(5):545-555. PubMed ID: 27854165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
    Agoba EE; Govinden U; Peer AKC; Osei Sekyere J; Essack SY
    Microb Drug Resist; 2018 Nov; 24(9):1289-1295. PubMed ID: 29653481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
    Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
    Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dissemination of IMP-1 and OXA type beta-lactamase in carbapenem-resistant Acinetobacter baumannii].
    Sung JY; Kwon KC; Park JW; Kim YS; Kim JM; Shin KS; Kim JW; Ko CS; Shin SY; Song JH; Koo SH
    Korean J Lab Med; 2008 Feb; 28(1):16-23. PubMed ID: 18309251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
    Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
    Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
    Jiang W; Liu H; Zhong M; Yang YC; Xiao DW; Huang WF
    Microb Drug Resist; 2013 Apr; 19(2):117-23. PubMed ID: 22845773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
    Poirel L; Nordmann P
    Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
    Jaidane N; Naas T; Mansour W; Radhia BB; Jerbi S; Boujaafar N; Bouallegue O; Bonnin RA
    Int J Antimicrob Agents; 2018 Feb; 51(2):266-269. PubMed ID: 29127051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.